pneumococcal infections
Showing 1 - 25 of 102
Pneumococcal Infections Trial in Adelaide (Gamma-PN3, Pneumovax-23, Prevenar-13)
Recruiting
- Pneumococcal Infections
- Gamma-PN3
- +3 more
-
Adelaide, South Australia, AustraliaUniversity of Adelaide
Aug 1, 2023
Pneumococcal Infections Trial in Leuven (AUDIT and Feedback)
Recruiting
- Pneumococcal Infections
- AUDIT and Feedback
-
Leuven, BelgiumAcademic Center of General Practice
Jun 17, 2023
COVID-19, Pneumococcal Infections Trial (NVX, PCV20, Placebo)
Not yet recruiting
- COVID-19
- Pneumococcal Infections
- NVX
- +2 more
- (no location specified)
Mar 13, 2023
Pneumococcal Infections Trial in Yuanping, Yuncheng (Experimental 23-valent Pneumococcal)
Not yet recruiting
- Pneumococcal Infections
- Experimental 23-valent Pneumococcal
-
Yuanping, Shanxi, China
- +1 more
Feb 7, 2023
Pneumococcal Infections, Pneumonia, Pneumococcal Trial in United States (Prevnar 13, AFX3772)
Recruiting
- Pneumococcal Infections
- Pneumonia, Pneumococcal
- Prevnar 13
- AFX3772
-
Jonesboro, Arkansas
- +31 more
Jan 19, 2023
Pneumococcal Infections Trial in Adelaide (Gamma-PN3, Prevenar-13, Pneumovax-23)
Recruiting
- Pneumococcal Infections
- Gamma-PN3
- +3 more
-
Adelaide, South Australia, AustraliaCMAX
Dec 29, 2022
Pneumococcal Infections Trial in Xiangtan (13-Valent Pneumococcal Polysaccharide Conjugate Vaccine)
Recruiting
- Pneumococcal Infections
- 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
-
Xiangtan, Hunan, ChinaXiangtan Maternal and Child Health Hospital
Nov 11, 2022
Pneumococcal Infections, Streptococcal Infections, Bacterial Infections Trial in Anyang (13-Valent Pneumococcal Polysaccharide
Active, not recruiting
- Pneumococcal Infections
- +2 more
- 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine(CRM197,TT)
- 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
-
Anyang, Henan, ChinaNeihuang Center for Disease Control and Prevention
Oct 28, 2022
Pneumococcal Infections Trial in Worldwide (V114, Prevnar 13™, PNEUMOVAX™23)
Completed
- Pneumococcal Infections
- V114
- +2 more
-
Palo Alto, California
- +51 more
Sep 23, 2022
Pneumococcal Infections Trial in Worldwide (V114, Prevnar 13™)
Completed
- Pneumococcal Infections
- V114
- Prevnar 13™
-
Downey, California
- +75 more
Sep 22, 2022
Pneumococcal Infections Trial in Kaifeng (Investigational 23-valent PPV, Control 23-valent PPV)
Completed
- Pneumococcal Infections
- Investigational 23-valent PPV
- Control 23-valent PPV
-
Kaifeng, Henan, ChinaKaifeng County Center for Disease Control and Prevention
Aug 10, 2022
Pneumococcal Infections Trial in Weinan (Experimental 23-valent PPV, Control 23-valent PPV)
Not yet recruiting
- Pneumococcal Infections
- Experimental 23-valent PPV
- Control 23-valent PPV
-
Weinan, Shanxi, ChinaLinwei District Center for Disease Control and Prevention
Jul 26, 2022
Hospitalized Pneumococcal Community Acquired Pneumonia in France
Recruiting
- Pneumonia
- +2 more
-
Rennes, Bretagne, FranceCHU Rennes
May 12, 2022
Immunization To Prevent Acute COPD Exacerbations
Recruiting
- Pneumococcal Infections
- COPD
-
Terrassa, Barcelona, Spain
- +10 more
Apr 26, 2022
Pneumonia, Bacterial, Cancer, Pneumococcal Infections Trial in Ankara (vaccine education)
Completed
- Pneumonia, Bacterial
- +2 more
- vaccine education
-
Ankara, TurkeyHacettepe University Faculty of Medicine Department of Medical O
Jan 27, 2022
Pneumococcal Infections, Pneumococcal Conjugate Vaccine Trial in Huaian, Lianyungang (13vPnC, Hib)
Active, not recruiting
- Pneumococcal Infections
- Pneumococcal Conjugate Vaccine
- 13vPnC
- Hib
-
Huaian, Jiangsu, China
- +1 more
Dec 17, 2021
Pneumococcal Vaccination in Chronic Lymphocytic Leukaemia
Recruiting
- Pneumococcal Infections
- +3 more
- Prevnar13
-
Amsterdam-Zuidoost, NetherlandsAmsterdam UMC Locatie AMC
Dec 3, 2021
Pneumococcal Infections Trial in Worldwide (Rotarix™, Infanrix™ hexa, V114)
Completed
- Pneumococcal Infections
- Rotarix™
- +3 more
-
South Brisbane, Queensland, Australia
- +59 more
Dec 1, 2021
Pneumococcal Infections Trial in United States (Multivalent, Prevnar 13)
Terminated
- Pneumococcal Infections
- Multivalent
- Prevnar 13
-
Mobile, Alabama
- +47 more
Nov 29, 2021
Pneumococcal Infections Trial in United States (13-valent pneumococcal conjugate vaccine (13vPnC), 23-valent Pneumococcal
Completed
- Pneumococcal Infections
- 13-valent pneumococcal conjugate vaccine (13vPnC)
- 23-valent Pneumococcal Polysaccharide Vaccine (23vPS)
-
Huntsville, Alabama
- +25 more
Nov 11, 2021
Pneumococcal Infections, HIV Trial (PPV-23 Vaccine, PCV-13 Vaccine, Placebo Vaccine)
Withdrawn
- Pneumococcal Infections
- HIV Infections
- PPV-23 Vaccine
- +2 more
- (no location specified)
Oct 28, 2021
HIV, Hepatitis B, Measles Trial in Puerto Rico, United States (Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine
Completed
- HIV Infections
- +4 more
- Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed
- +4 more
-
Birmingham, Alabama
- +39 more
Oct 28, 2021
Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of
Completed
- Mycobacterium Avium-intracellulare Infection
- +2 more
-
San Francisco, California
- +14 more
Oct 27, 2021
HIV, Pneumococcal Infections Trial in Puerto Rico, United States (Pneumococcal Vaccine, Polyvalent (23-valent), Pneumococcal
Completed
- HIV Infections
- Pneumococcal Infections
- Pneumococcal Vaccine, Polyvalent (23-valent)
- +2 more
-
Los Angeles, California
- +32 more
Oct 27, 2021